Association between Inflammation and Function of Cell Adhesion Molecules Influence on Gastrointestinal Cancer Development.
cell adhesion molecule
gastrointestinal cancer
inflammation
tumor microenvironment
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
04 01 2021
04 01 2021
Historique:
received:
02
11
2020
revised:
09
12
2020
accepted:
29
12
2020
entrez:
7
1
2021
pubmed:
8
1
2021
medline:
25
8
2021
Statut:
epublish
Résumé
Gastrointestinal cancer is highly associated with inflammatory processes inducing the release of cytokines from cancer or immune cells, including interferons, interleukins, chemokines, colony-stimulating factors, and growth factors, which promote or suppress tumor progression. Inflammatory cytokines within the tumor microenvironment promote immune cell infiltration. Infiltrating immune, and tumor-surrounding stromal cells support tumor growth, angiogenesis, metastasis, and immunosuppression through communication with inflammatory cytokines and cell adhesion molecules. Notably, infiltrating immune and tumor cells present immunosuppressive molecules, such as programmed death-ligand 1 (PD-L1) and CD80/CD86. Suppression of cytotoxic T cells promotes tumor avoidance of immune surveillance and greater malignancy. Moreover, glycosylation and sialylation of proteins hyperexpressed on the cancer cell surface have been shown to enhance immune escape and metastasis. Cytokine treatments and immune checkpoint inhibitors are widely used in clinical practice. However, the tumor microenvironment is a rapidly changing milieu involving several factors. In this review, we have provided a summary of the interactions of inflammation and cell adhesion molecules between cancer and other cell types, to improve understanding of the tumor microenvironment.
Identifiants
pubmed: 33406733
pii: cells10010067
doi: 10.3390/cells10010067
pmc: PMC7824562
pii:
doi:
Substances chimiques
Cell Adhesion Molecules
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Review
Langues
eng
Sous-ensembles de citation
IM
Références
Oncol Rep. 2016 May;35(5):2499-515
pubmed: 26986034
Gastroenterology. 2020 Feb;158(3):679-692.e1
pubmed: 31711924
J Biomed Sci. 2019 Oct 20;26(1):78
pubmed: 31629410
Oncogene. 2014 Mar 27;33(13):1658-69
pubmed: 23604127
Cancer Res. 2007 Feb 1;67(3):1038-45
pubmed: 17283136
Exp Cell Res. 2006 Dec 10;312(20):4056-69
pubmed: 17056038
Br J Cancer. 2019 Mar;120(5):527-536
pubmed: 30723303
Cancer Cell. 2019 Mar 18;35(3):347-367
pubmed: 30889378
Biochimie. 2001 Jul;83(7):615-22
pubmed: 11522390
Cell Physiol Biochem. 2018;47(2):721-734
pubmed: 29794465
J Clin Oncol. 2011 Jul 10;29(20):2787-94
pubmed: 21632504
World J Surg Oncol. 2013 May 30;11:118
pubmed: 23718886
Histochem Cell Biol. 2017 Feb;147(2):149-174
pubmed: 27975143
Cancer Res. 2011 Mar 1;71(5):1989-98
pubmed: 21363926
Cardiovasc Res. 2015 Aug 1;107(3):331-9
pubmed: 25994174
Tumour Biol. 2018 Nov;40(11):1010428318810059
pubmed: 30419802
J Immunol. 2018 Jan 15;200(2):422-431
pubmed: 29311384
PLoS One. 2014 Aug 04;9(8):e94995
pubmed: 25089569
Cell Cycle. 2009 Oct 15;8(20):3267-73
pubmed: 19770594
Oncotarget. 2017 Dec 14;9(6):7204-7218
pubmed: 29467962
J Cell Physiol. 1998 Nov;177(2):324-33
pubmed: 9766529
J Surg Res. 2019 Aug;240:115-123
pubmed: 30927618
Mod Pathol. 2016 Sep;29(9):1104-12
pubmed: 27198569
Immunity. 2019 Jan 15;50(1):166-180.e7
pubmed: 30650375
EPMA J. 2019 Nov 20;10(4):365-381
pubmed: 31832112
Sci Rep. 2017 Aug 15;7(1):8265
pubmed: 28811578
J Immunol. 2011 Jun 15;186(12):6822-9
pubmed: 21555531
Sci Rep. 2018 Jan 22;8(1):1323
pubmed: 29358632
Front Oncol. 2018 Aug 21;8:322
pubmed: 30186768
Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2193-8
pubmed: 11854515
Glycobiology. 2018 Sep 1;28(9):648-655
pubmed: 29272415
Int J Med Sci. 2020 Apr 27;17(8):1095-1101
pubmed: 32410839
Cell. 2018 Jan 25;172(3):564-577.e13
pubmed: 29275858
BMC Cancer. 2019 Nov 6;19(1):1053
pubmed: 31694582
Oncol Rep. 2019 Dec;42(6):2267-2278
pubmed: 31578587
Exp Cell Res. 2017 Sep 1;358(1):78-85
pubmed: 28412244
J Immunol Res. 2014;2014:149185
pubmed: 24901008
J Formos Med Assoc. 2019 Mar;118 Suppl 1:S32-S41
pubmed: 30655033
Int J Biol Sci. 2020 Feb 4;16(6):1023-1034
pubmed: 32140070
Immunopharmacol Immunotoxicol. 2019 Jun;41(3):386-393
pubmed: 30422018
Oncogene. 2019 May;38(22):4250-4263
pubmed: 30700829
Cancer Res. 2016 Jul 15;76(14):4028-31
pubmed: 27655809
Front Immunol. 2017 Jul 26;8:878
pubmed: 28798748
Oncogene. 2018 Feb 8;37(6):744-755
pubmed: 29059156
Int J Mol Med. 2013 Jul;32(1):93-100
pubmed: 23670240
Front Immunol. 2018 Aug 09;9:1859
pubmed: 30140269
Onco Targets Ther. 2016 Aug 12;9:5023-39
pubmed: 27574444
Int J Oncol. 2018 Aug;53(2):737-749
pubmed: 29767252
Nat Rev Immunol. 2018 Jul;18(7):417
pubmed: 29899366
Nat Rev Immunol. 2006 Nov;6(11):836-48
pubmed: 17063185
Glycobiology. 2016 Feb;26(2):111-28
pubmed: 26518624
Proc Natl Acad Sci U S A. 2002 Sep 3;99(18):11736-41
pubmed: 12192086
Gynecol Oncol. 2016 May;141(2):293-302
pubmed: 26972336
Nat Rev Mol Cell Biol. 2005 Aug;6(8):622-34
pubmed: 16025097
Nature. 2008 Jul 24;454(7203):428-35
pubmed: 18650913
Nat Rev Mol Cell Biol. 2012 Oct;13(10):616-30
pubmed: 22992590
Clin Cancer Res. 2005 Nov 1;11(21):7629-36
pubmed: 16278381
Cancer Chemother Pharmacol. 2016 Apr;77(4):847-56
pubmed: 26988221
J Exp Clin Cancer Res. 2019 Nov 4;38(1):449
pubmed: 31684995
Expert Opin Investig Drugs. 2013 Jul;22(7):827-41
pubmed: 23594171
J Cell Biochem. 2018 Dec;119(12):9997-10004
pubmed: 30145830
BMC Cancer. 2017 May 30;17(1):384
pubmed: 28558708
Curr Opin Drug Discov Devel. 2009 Mar;12(2):240-5
pubmed: 19333869
Cell Death Dis. 2019 Sep 18;10(10):693
pubmed: 31534132
Immunol Lett. 2017 Apr;184:7-14
pubmed: 28223102
Cancer Cell Int. 2018 Apr 2;18:50
pubmed: 29618949
Nat Rev Immunol. 2015 Jul;15(7):405-14
pubmed: 26027717
Int J Mol Sci. 2018 Jan 24;19(2):
pubmed: 29364163
J Exp Clin Cancer Res. 2016 Feb 04;35:27
pubmed: 26847351
Int J Biol Sci. 2018 Jun 3;14(9):1054-1066
pubmed: 29989092
Cell. 2014 Feb 13;156(4):744-58
pubmed: 24529377
Biomed Res Int. 2013;2013:570909
pubmed: 24024201
Cancer Lett. 2019 Jul 1;453:10-20
pubmed: 30922919
Cancer Res. 2018 Sep 1;78(17):4957-4970
pubmed: 29976575
Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1090-5
pubmed: 24395807
J Pathol. 2018 May;245(1):41-52
pubmed: 29431199
Nat Rev Cancer. 2018 Sep;18(9):533-548
pubmed: 30002479
Cancer Immunol Immunother. 2020 Aug;69(8):1477-1492
pubmed: 32285172
Chin J Cancer. 2012 Dec;31(12):557-63
pubmed: 23149314
Oncogene. 2017 Jun 22;36(25):3599-3608
pubmed: 28166197
Cell Cycle. 2019 Dec;18(24):3589-3602
pubmed: 31739702
Immunity. 2000 Feb;12(2):121-7
pubmed: 10714678
J Immunother Cancer. 2019 Feb 26;7(1):54
pubmed: 30808413
EMBO Mol Med. 2020 Jan 9;12(1):e10681
pubmed: 31793740
Meta Gene. 2015 Aug 26;6:9-16
pubmed: 26380815
BMC Cancer. 2020 Sep 23;20(1):913
pubmed: 32967656
Anticancer Res. 2008 May-Jun;28(3A):1499-507
pubmed: 18630504
Theranostics. 2019 Apr 13;9(8):2361-2379
pubmed: 31149049
PLoS One. 2017 Aug 10;12(8):e0182692
pubmed: 28796808
Pathol Res Pract. 2018 Jul;214(7):986-992
pubmed: 29803656
Cell. 2006 Sep 8;126(5):855-67
pubmed: 16959566
Hepatology. 2020 Sep;72(3):997-1012
pubmed: 31903610
Cancer Immunol Res. 2013 Dec;1(6):351-6
pubmed: 24524092
Gut. 2017 Nov;66(11):1878-1880
pubmed: 28348197
Transl Oncol. 2018 Feb;11(1):182-192
pubmed: 29306706
Cell. 2014 Apr 10;157(2):382-394
pubmed: 24725405
Proteomics. 2019 Nov;19(21-22):e1800452
pubmed: 31373757
Oncol Rep. 2018 Nov;40(5):2997-3005
pubmed: 30226606
Cell. 2019 May 16;177(5):1172-1186.e14
pubmed: 31031009
Cancer Lett. 2017 Jun 1;395:31-44
pubmed: 28268166
Int Immunol. 2016 Jul;28(7):319-28
pubmed: 27235694
Clin Dev Immunol. 2012;2012:948098
pubmed: 22778768
Nat Immunol. 2016 Mar;17(3):230-40
pubmed: 26882261
Neoplasia. 2018 Jan;20(1):57-68
pubmed: 29195126
Exp Cell Res. 2019 May 1;378(1):41-50
pubmed: 30844387
Cancer Res. 2013 Jun 15;73(12):3591-603
pubmed: 23633484
Proc Natl Acad Sci U S A. 2016 Sep 13;113(37):10304-9
pubmed: 27551071
J Int Med Res. 2018 Dec;46(12):5228-5236
pubmed: 30304975
Biomed Res Int. 2017;2017:4346576
pubmed: 28758114
Microbiol Mol Biol Rev. 2012 Mar;76(1):16-32
pubmed: 22390970
Ann Surg Oncol. 2019 Oct;26(11):3745-3755
pubmed: 31087180
Cell Death Dis. 2016 Apr 21;7:e2201
pubmed: 27100895
J Hematol Oncol. 2017 Feb 1;10(1):36
pubmed: 28143526
Cancer Sci. 2008 Aug;99(8):1501-6
pubmed: 18754859
Int J Mol Sci. 2019 Oct 21;20(20):
pubmed: 31640265
J Physiol Biochem. 2019 Jun;75(2):199-207
pubmed: 30972697
J Exp Clin Cancer Res. 2015 Nov 18;34:141
pubmed: 26581194
Trends Mol Med. 2008 Aug;14(8):351-60
pubmed: 18606570
Nat Rev Cancer. 2015 Sep;15(9):540-55
pubmed: 26289314
Oncotarget. 2017 Jan 3;8(1):1678-1687
pubmed: 27926494
Gut. 2017 Nov;66(11):1900-1911
pubmed: 28274999
Cent Eur J Immunol. 2016;41(4):358-362
pubmed: 28450798
Nat Rev Immunol. 2014 Jan;14(1):36-49
pubmed: 24362405
NPJ Precis Oncol. 2018 Jan 23;2(1):2
pubmed: 29872721
EBioMedicine. 2019 Feb;40:446-456
pubmed: 30594557
Cell. 2000 Jan 7;100(1):57-70
pubmed: 10647931
Cancer Lett. 2019 Jul 10;454:37-43
pubmed: 30978440
Nat Commun. 2019 Jul 11;10(1):3071
pubmed: 31296856
Free Radic Biol Med. 2010 Dec 1;49(11):1603-16
pubmed: 20840865
Oncol Rep. 2019 Aug;42(2):595-604
pubmed: 31233202
EBioMedicine. 2020 Sep;59:102975
pubmed: 32853984
Am J Pathol. 2003 Mar;162(3):793-801
pubmed: 12598314
Oncol Lett. 2018 Jan;15(1):509-514
pubmed: 29387231
Cancer Res. 2018 Jul 1;78(13):3574-3588
pubmed: 29703719
Cancer Biol Ther. 2011 Sep 15;12(6):494-502
pubmed: 21725207
Cancer Res. 2014 Feb 1;74(3):716-26
pubmed: 24366884
Int J Mol Sci. 2018 May 16;19(5):
pubmed: 29772686
Immunotherapy. 2017 Mar;9(4):347-360
pubmed: 28303764
Gastroenterology. 2018 Apr;154(5):1524-1537.e6
pubmed: 29274868
Front Immunol. 2018 May 04;9:847
pubmed: 29780381
Clin Cancer Res. 2014 May 1;20(9):2276-88
pubmed: 24602839
BMC Cancer. 2019 Aug 13;19(1):799
pubmed: 31409309
Cancer Sci. 2018 Jan;109(1):43-53
pubmed: 29034543
Clin Epigenetics. 2018 Dec 12;10(1):154
pubmed: 30541610
FEBS Lett. 2012 Aug 31;586(18):2981-9
pubmed: 22841718
Gut. 2019 Oct;68(10):1764-1773
pubmed: 30661053
Int J Mol Sci. 2018 May 29;19(6):
pubmed: 29844297
Mol Cancer. 2020 Aug 6;19(1):120
pubmed: 32762681
Oncol Lett. 2019 Dec;18(6):5871-5878
pubmed: 31788060
Nat Rev Immunol. 2020 Jun;20(6):363-374
pubmed: 32346093
Front Oncol. 2019 May 14;9:380
pubmed: 31157165
Oncoimmunology. 2019 Jul 13;8(9):e1626193
pubmed: 31428524
J Immunother Cancer. 2019 Jun 22;7(1):157
pubmed: 31228946
Asian Pac J Cancer Prev. 2013;14(9):5513-8
pubmed: 24175851
ISRN Hepatol. 2013 Sep 15;2013:412317
pubmed: 27335826
Oncotarget. 2018 Jul 3;9(51):29820-29841
pubmed: 30038723
Biochim Biophys Acta Gene Regul Mech. 2019 Feb;1862(2):173-183
pubmed: 30716533
Cancer Lett. 2017 Jan 28;385:28-38
pubmed: 27832972
World J Gastroenterol. 2002 Aug;8(4):591-5
pubmed: 12174362
J Biol Chem. 2012 Feb 17;287(8):5819-32
pubmed: 22205702